Candriam S.C.A. - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 163 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.72 and the average weighting 0.6%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$2,160,000
+103.8%
142,745
-5.5%
0.02%
+114.3%
Q4 2021$1,060,000
-85.8%
151,000
-73.8%
0.01%
-88.7%
Q1 2021$7,481,000
-4.0%
576,4950.0%0.06%0.0%
Q4 2020$7,789,000
+11.8%
576,495
-2.6%
0.06%
-4.6%
Q3 2020$6,965,000
-20.3%
591,8000.0%0.06%
-29.3%
Q2 2020$8,735,000
-44.8%
591,800
-11.6%
0.09%
-47.4%
Q1 2020$15,826,000
-2.2%
669,8000.0%0.18%
+0.6%
Q4 2019$16,189,000
+20.4%
669,800
-4.3%
0.17%
-2.2%
Q3 2019$13,450,000
-24.4%
699,800
+15.7%
0.18%
-19.8%
Q2 2019$17,793,000
-38.1%
604,8000.0%0.22%
-39.7%
Q1 2019$28,729,000
+66.2%
604,800
+26.3%
0.37%
+38.3%
Q4 2018$17,284,000
-14.1%
478,800
+46.5%
0.27%
-0.4%
Q3 2018$20,115,000
+144.7%
326,800
+168.5%
0.27%
+105.4%
Q2 2018$8,221,000
+91.8%
121,700
+54.1%
0.13%
+78.1%
Q1 2018$4,286,000
-0.4%
79,000
+9.7%
0.07%
-1.4%
Q4 2017$4,302,000
+50.1%
72,000
+22.0%
0.07%
+48.0%
Q3 2017$2,867,000
+36.4%
59,000
+47.5%
0.05%
+25.0%
Q2 2017$2,102,000
+54.4%
40,000
+33.3%
0.04%
+53.8%
Q1 2017$1,361,000
+5.7%
30,000
-11.8%
0.03%
-13.3%
Q4 2016$1,287,000
+0.3%
34,0000.0%0.03%
-3.2%
Q3 2016$1,283,000
-83.2%
34,000
-86.0%
0.03%
-79.7%
Q1 2015$7,617,000
-15.8%
243,000
-21.6%
0.15%
-19.0%
Q4 2014$9,049,000310,0000.19%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
LEVIN CAPITAL STRATEGIES, L.P. 1,373,542$15,658,0001.56%
DAFNA Capital Management LLC 289,040$3,295,0000.87%
Integral Health Asset Management, LLC 250,000$2,850,0000.82%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 193,266$2,203,0000.80%
PFM Health Sciences, LP 2,182,684$24,883,0000.73%
DCF Advisers, LLC 136,501$1,556,0000.69%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,977,020$33,938,0000.66%
NEXPOINT ASSET MANAGEMENT, L.P. 309,778$3,532,0000.61%
Rhenman & Partners Asset Management AB 750,000$8,550,0000.60%
RICE HALL JAMES & ASSOCIATES, LLC 1,232,600$14,052,0000.52%
View complete list of AERIE PHARMACEUTICALS INC shareholders